How to cite item

High dose Bacillus Calmette-Guerin (BCG) for urothelial carcinoma is trickier than expected

   
@article{TCR11959,
	author = {Mohammad R. Siddiqui and Piyush K. Agarwal},
	title = {High dose Bacillus Calmette-Guerin (BCG) for urothelial carcinoma is trickier than expected},
	journal = {Translational Cancer Research},
	volume = {6},
	number = {Suppl 1},
	year = {2017},
	keywords = {},
	abstract = {Intravesical instillation of Bacillus Clamette-Guerin (BCG) is the first line adjuvant therpay to transuretheral resection of bladder tumor (TURBT) for patients with intermediateand high-risk non-muslce invasive bladder cancer (NMIBC) lesions (1). Its effectiveness, however, comes at a cost of complications, with up to 91% of patients developing some type of irritative local symptoms (1). Additionally, about 10– 20% of responders and 66% of non-responders eventually progress to muscle-invasive disease, leaving them with an invasive option of cystoprostatectomy (2).},
	issn = {2219-6803},	url = {https://tcr.amegroups.org/article/view/11959}
}